Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection
- PMID: 28104365
- PMCID: PMC5487289
- DOI: 10.1016/j.bbabio.2017.01.004
Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection
Abstract
Mitochondrial dysfunction is a hallmark of many diseases. The retrograde signaling initiated by dysfunctional mitochondria can bring about global changes in gene expression that alters cell morphology and function. Typically, this is attributed to disruption of important mitochondrial functions, such as ATP production, integration of metabolism, calcium homeostasis and regulation of apoptosis. Recent studies showed that in addition to these factors, mitochondrial dynamics might play an important role in stress signaling. Normal mitochondria are highly dynamic organelles whose size, shape and network are controlled by cell physiology. Defective mitochondrial dynamics play important roles in human diseases. Mitochondrial DNA defects and defective mitochondrial function have been reported in many cancers. Recent studies show that increased mitochondrial fission is a pro-tumorigenic phenotype. In this paper, we have explored the current understanding of the role of mitochondrial dynamics in pathologies. We present new data on mitochondrial dynamics and dysfunction to illustrate a causal link between mitochondrial DNA defects, excessive fission, mitochondrial retrograde signaling and cancer progression. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux.
Keywords: Mitochondrial dysfunction; cancer; mitochondrial dynamics; mitochondrial fission; retrograde signaling.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures







Similar articles
-
Mitochondria and cancer chemoresistance.Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):686-699. doi: 10.1016/j.bbabio.2017.01.012. Epub 2017 Feb 1. Biochim Biophys Acta Bioenerg. 2017. PMID: 28161329 Review.
-
Dysregulation of mitophagy in carcinogenesis and tumor progression.Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):633-640. doi: 10.1016/j.bbabio.2016.12.008. Epub 2016 Dec 23. Biochim Biophys Acta Bioenerg. 2017. PMID: 28017650 Review.
-
Mitochondrial metabolism and energy sensing in tumor progression.Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):582-590. doi: 10.1016/j.bbabio.2017.02.006. Epub 2017 Feb 14. Biochim Biophys Acta Bioenerg. 2017. PMID: 28213331 Review.
-
Calcium regulates cell death in cancer: Roles of the mitochondria and mitochondria-associated membranes (MAMs).Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):615-627. doi: 10.1016/j.bbabio.2017.01.003. Epub 2017 Jan 10. Biochim Biophys Acta Bioenerg. 2017. PMID: 28087257 Review.
-
VDAC in cancer.Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):665-673. doi: 10.1016/j.bbabio.2017.03.002. Epub 2017 Mar 7. Biochim Biophys Acta Bioenerg. 2017. PMID: 28283400 Review.
Cited by
-
Danggui Buxue Decoction Ameliorates Idiopathic Pulmonary Fibrosis through MicroRNA and Messenger RNA Regulatory Network.Evid Based Complement Alternat Med. 2022 Apr 26;2022:3439656. doi: 10.1155/2022/3439656. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35518349 Free PMC article.
-
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.Cancer Biol Ther. 2018;19(11):1023-1032. doi: 10.1080/15384047.2018.1472193. Epub 2018 Oct 12. Cancer Biol Ther. 2018. PMID: 30311833 Free PMC article.
-
Reshaping membranes to build mitochondrial DNA.PLoS Genet. 2019 Jun 6;15(6):e1008140. doi: 10.1371/journal.pgen.1008140. eCollection 2019 Jun. PLoS Genet. 2019. PMID: 31170157 Free PMC article. No abstract available.
-
Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway.Onco Targets Ther. 2019 Mar 1;12:1765-1779. doi: 10.2147/OTT.S196142. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881030 Free PMC article.
-
Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer.Front Oncol. 2017 Dec 1;7:295. doi: 10.3389/fonc.2017.00295. eCollection 2017. Front Oncol. 2017. PMID: 29250487 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases